FSD Pharma Inc. | WebDisclosure

Basculer en Français

10805	Companies
233918	Keywords
162615	Articles
124934	Press releases

Home
Companies
FSD Pharma Inc.

PRESS RELEASE

published on 05/31/2024 at 13:30, 2 years 2 months ago

FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest
FSD Pharma Inc. confirms arbitration awards against former CEO Dr. Raza Bokhari. United States District Court grants final judgment for monetary damages. Company focuses on biopharmaceutical solutions for neurodegenerative disorders

FSD Pharma Inc. Arbitration Awards Neurodegenerative Disorders United States District Court Biopharmaceutical Solutions
BRIEF

published on 05/28/2024 at 14:05, 2 years 2 months ago

FSD Pharma soumet un protocole d'essai clinique pour Unbuzzd™ dans le traitement de l'intoxication alcoolique aiguë

FSD Pharma Essai Clinique Unbuzzd™ Intoxication Alcoolique Essai METAL-2
BRIEF

published on 05/28/2024 at 14:05, 2 years 2 months ago

FSD Pharma Submits Clinical Trial Protocol for Unbuzzd™ in Acute Alcohol Intoxication

FSD Pharma Clinical Trial Unbuzzd™ Alcohol Intoxication METAL-2 Trial
PRESS RELEASE

published on 05/28/2024 at 14:00, 2 years 2 months ago

FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
FSD Pharma submits clinical trial protocol for Unbuzzd(TM) to assess safety and efficacy in a crossover design trial to study effects on alcohol intoxication. Dr. Andrzej Chruscinski comments on the milestone reached

FSD Pharma Unbuzzd(TM) Alcohol Intoxication Clinical Trial Protocol Dr. Andrzej Chruscinski
BRIEF

published on 05/24/2024 at 20:39, 2 years 2 months ago

FSD Pharma annonce un accord de relations avec les investisseurs avec IR Agency LLC

Biopharmaceutique FSD Pharma Relations Avec Les Investisseurs Agence RI Psychéeutiques Lucides
BRIEF

published on 05/24/2024 at 20:39, 2 years 2 months ago

FSD Pharma Announces Investor Relations Agreement with IR Agency LLC

Investor Relations FSD Pharma Biopharmaceutical IR Agency Lucid Psycheceuticals
PRESS RELEASE

published on 05/24/2024 at 20:34, 2 years 2 months ago

FSD Pharma Provides Corporate Update
FSD Pharma Inc. enters investor relations services agreement with IR Agency LLC, focusing on communicating information to the financial community. Company building innovative biotech solutions

Investor Relations FSD Pharma Inc. Biopharmaceutical Innovative Assets IR Agency LLC
BRIEF

published on 05/16/2024 at 14:05, 2 years 2 months ago

FSD Pharma Announces New Packaging for Unbuzzd™ Beverage

FSD Pharma Beverage Industry Unbuzzd New Packaging Responsible Drinking
BRIEF

published on 05/16/2024 at 14:05, 2 years 2 months ago

FSD Pharma annonce un nouvel emballage pour la boisson Unbuzzd™

FSD Pharma L'industrie Des Boissons Consommation Responsable Unbuzzd Nouvel Emballage
PRESS RELEASE

published on 05/16/2024 at 14:00, 2 years 2 months ago

FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM)
FSD Pharma Inc. announces new packaging and logo for unbuzzd™ beverage product in collaboration with Celly Nutrition Corp. and Six+One, set to launch this summer, targeting alcohol metabolizing and promoting alertness

FSD Pharma Inc. Celly Nutrition Corp. Unbuzzd Six+One Packaging Logo

Accesswire

Published on 08/06/2026 at 03:35, 4 hours 11 minutes ago

Tunkillia Upgrade Drilling – 39,000m Phase 2 Complete Targeting JORC Resource Classification Upgrades; PFS Underway
Published on 08/06/2026 at 01:40, 6 hours 6 minutes ago

Taranis Identifies a Hydrothermally Altered, Sulfide-Bearing Intrusive Stock Associated with Historic Gold-Silver Occurrence and Connected to Thor
Published on 08/05/2026 at 23:40, 8 hours 6 minutes ago

Galantas Gold Secures Key Permitting Approvals for Andacollo Gold Project
Published on 08/05/2026 at 23:10, 8 hours 36 minutes ago

Ur-Energy Announces Date for Second Quarter 2026 Results and Conference Call and Webcast
Published on 08/05/2026 at 23:01, 8 hours 45 minutes ago

Full Circle Lithium Announces Extension of Current Private Placement

View all ACCESSWIRE

EQS Group

Published on 08/06/2026 at 07:33, 13 minutes ago

1&1 reports half-year results, forecast for 2026 confirmed
Published on 08/06/2026 at 07:31, 15 minutes ago

Henkel delivers strong sales and earnings performance in the first half and upgrades top-line expectations for 2026
Published on 08/06/2026 at 07:30, 16 minutes ago

Nordex Group secures a major order in Türkiye totalling 525 MW
Published on 08/06/2026 at 07:30, 16 minutes ago

Instone Group: Strong operating cash flow in H1; geopolitical uncertainties dampen the recovery in demand
Published on 08/06/2026 at 07:30, 16 minutes ago

SGL Carbon: Still on track to meet its 2026 annual targets

Les Echos

Published on 08/05/2026 at 18:00, 13 hours 46 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026
Published on 08/05/2026 at 18:00, 13 hours 46 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 13 hours 56 minutes ago

Mersen : nombre d'actions et de droits de vote au 31 juillet 2026
Published on 08/05/2026 at 17:49, 13 hours 56 minutes ago

Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 14 hours 1 minute ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE